CoChat

Hyperglycemia and Adverse Pregnancy Outcomes

Metzger, Boyd E, Coustan, Donald R, Trimble, Elisabeth R · 2019 · Clinical Chemistry
Cited by 121

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Featured Article: Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al., for the HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.4 Criteria for the diagnosis of gestational diabetes mellitus (GDM)5 based on association of levels of glycemia during pregnancy with subsequent maternal diabetes were first published 55 years ago (1). With adjustments for measurement of glucose in plasma rather than in whole blood and use of enzymatic methods, these criteria remain in use in the US and some other areas. Despite recognition of GDM by various professional organizations in 1979 to 1980, questions remained: (a) Were adverse outcomes attributed to GDM linked to maternal hyperglycemia or to confounding factors such as obesity, maternal age, and less socioeconomic advantage, and (b) did GDM treatment reduce adverse outcomes? The first question was addressed by the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study, published in the article featured here. The hypothesis was that hyperglycemia in pregnancy, less severe than diabetes, was associated with increased risk of adverse maternal, fetal, and neonatal outcomes independently related to the degree of metabolic disturbance. Eligible women at 15 sites from 9 countries underwent a 75-g, 2-h oral glucose tolerance test (OGTT) at 24 to 32 weeks' gestation, with the target being 28 weeks. Samples were drawn fasting and at 1 h and 2 h after the glucose load. Fasting, 2-h, and random plasma glucose levels at 34 to 37 weeks' gestation were analyzed in local field center laboratories to identify the need for unblinding. Aliquots of the OGTT were analyzed at the central laboratory of the HAPO Study, and these results were used in the analyses reported in the article; 25505 eligible women completed an OGTT. Participants were unblinded with glucose values outside a prespecified range, failure to complete the study usually because of delivery at another hospital, or unanticipated glucose testing for clinical reasons. A total of 23316 women completed the study. Associations of maternal fasting, 1-h, and 2-h 75-g OGTT values with primary study outcomes birth weight above the 90th percentile for gestational age, primary cesarean delivery, clinically diagnosed neonatal hypoglycemia, and cord-blood serum C-peptide above the 90th percentile were continuous. There were no obvious thresholds at which risks increased. Significant associations were also observed for secondary outcomes, although these tended to be weaker.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2019.303990

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 121

Metadata

Authors
Metzger, B. E., Coustan, D. R., & Trimble, E. R.
Venue
Clinical Chemistry
Published
2019-07-01
Volume
65
Issue
7
Pages
937-938
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2938285180
Cited by
121
References
4
FWCI
11.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.